Literature DB >> 11981416

Etiology of diarrhea in patients undergoing allogeneic bone marrow transplantation in South India.

Gagandeep Kang1, Alok Srivastava, Anna B Pulimood, David Dennison, Mammen Chandy.   

Abstract

BACKGROUND: No studies so far have examined enteric infections in patients undergoing bone marrow transplantation (BMT) in developing countries where asymptomatic carriage and colonization with enteric pathogens is frequent.
METHODS: A prospective study followed 65 patients who underwent BMT in South India between 1995 and 1998. Patients were screened for enteric pathogens before transplantation, weekly during the first 4 weeks after transplantation, and during all episodes of diarrhea.
RESULTS: Enteric pathogens were found in 60% of patients before or after transplantation. Pretransplantation screening revealed asymptomatic excretion of enteric pathogens in 29% (19/65). Forty-eight percent of patients undergoing BMT developed diarrhea. Diarrhea was mainly of noninfectious origin in the first 20 days after transplantation. More than 20 days after transplantation, the major causes of diarrhea were graft-versus-host disease and infection. Parasitic infections other than Cryptosporidium did not contribute significantly to morbidity in the pre- and posttransplantation period. Rotavirus and adenoviruses were found in approximately 12% and 5% of subjects, respectively. Bacterial infections in the posttransplantation period were found to be more common in India than in developed countries. Clostridium difficile-associated diarrhea was seen in the posttransplantation period but not before transplantation. Enterotoxigenic and enterohemorrhagic Escherichia coli caused symptomatic infections in the posttransplantation period, but the association of other classes of diarrheogenic E. coli with diarrhea was doubtful.
CONCLUSIONS: There was significantly higher mortality (P<0.01) in patients with symptomatic or asymptomatic gastrointestinal infections caused by bacteria than in patients with parasitic or viral infections or without enteric infections.

Entities:  

Mesh:

Year:  2002        PMID: 11981416     DOI: 10.1097/00007890-200204270-00010

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

Review 1.  Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.

Authors:  Carolyn D Alonso; Kieren A Marr
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

Review 2.  Clostridium difficile infection: clinical spectrum and approach to management.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2011-12-20

3.  Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?

Authors:  J Delaloye; G Merlani; C Petignat; A Wenger; K Zaman; C Monnerat; O Matzinger; M Beck Popovic; P Vuichard; N Ketterer; P E Tarr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

Review 4.  Fidaxomicin--the new drug for Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

5.  Molecular appraisal of intestinal parasitic infection in transplant recipients.

Authors:  Pooja Yadav; Shehla Khalil; Bijay Ranjan Mirdha
Journal:  Indian J Med Res       Date:  2016-08       Impact factor: 2.375

6.  Detection of Cryptosporidium in stool samples of immunocompromised patients.

Authors:  K Vanathy; Subhash Chandra Parija; Jharna Mandal; Abdoul Hamide; Sriram Krishnamurthy
Journal:  Trop Parasitol       Date:  2017 Jan-Jun

7.  Cryptosporidiosis: An under-recognized public health problem.

Authors:  Niyati T Desai; Rajiv Sarkar; Gagandeep Kang
Journal:  Trop Parasitol       Date:  2012-07

Review 8.  Cryptosporidiosis: A mini review.

Authors:  K Vanathy; Subhash Chandra Parija; Jharna Mandal; Abdoul Hamide; Sriram Krishnamurthy
Journal:  Trop Parasitol       Date:  2017 Jul-Dec

9.  Giardia lamblia mimicking acute graft versus host disease after allogeneic hematopoietic stem cell transplantation: A case report.

Authors:  Shengling Ma; Han Yan; Wei Shi; Yong You; Zhao-Dong Zhong; Yu Hu
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.